Skip to main content

Johnson & Johnson Innovative Medicine revenue

  • JNJ · NYSE
  • Healthcare
  • Pharmaceuticals
  • S&P 500
$285.75+0.79%Close 13 Nov 2026 · Market value $684.4B

Innovative Medicine revenue at Johnson & Johnson came to $16.8B for the quarter to 27 Sep 2026, up 7.7% from a year earlier.

As Johnson & Johnson reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 21 Oct 2026.

By quarter

$13.7BDec 2023$13.6BMar 2024$14.5BJun 2024$14.6BSep 2024$14.3BDec 2024$13.9BMar 2025$15.2BJun 2025$15.6BSep 2025$15.8BDec 2025$15.4BMar 2026$16.4BJun 2026$16.8BSep 2026
Johnson & Johnson Innovative Medicine revenue, every reported period
Period endingInnovative Medicine revenueChange on a yearFiled
27 Sep 2026$16.8Bup 7.7%21 Oct 2026
28 Jun 2026$16.4Bup 7.8%23 Jul 2026
29 Mar 2026$15.4Bup 11.2%22 Apr 2026
28 Dec 2025$15.8Bup 10.0%11 Feb 2026
28 Sep 2025$15.6Bup 6.7%22 Oct 2025
29 Jun 2025$15.2Bup 4.9%24 Jul 2025
30 Mar 2025$13.9Bup 2.3%23 Apr 2025
29 Dec 2024$14.3Bup 4.4%13 Feb 2025
29 Sep 2024$14.6Bup 4.9%23 Oct 2024
30 Jun 2024$14.5Bup 5.5%25 Jul 2024
31 Mar 2024$13.6Bup 1.1%1 May 2024
31 Dec 2023$13.7Bup 4.2%16 Feb 2024
1 Oct 2023$13.9Bup 5.1%27 Oct 2023
2 Jul 2023$13.7Bup 3.1%31 Jul 2023
2 Apr 2023$13.4Bup 4.2%28 Apr 2023
1 Jan 2023$13.2Bdown 7.4%16 Feb 2023
2 Oct 2022$13.2Bup 2.6%27 Oct 2022
3 Jul 2022$13.3Bup 6.7%29 Jul 2022
3 Apr 2022$12.9Bup 6.3%29 Apr 2022
2 Jan 2022$14.2Bup 15.9%17 Feb 2022
3 Oct 2021$12.9Bup 12.8%29 Oct 2021
4 Jul 2021$12.5Bup 16.1%29 Jul 2021
4 Apr 2021$12.1Bup 8.7%30 Apr 2021
3 Jan 2021$12.3Bup 16.3%22 Feb 2021
27 Sep 2020$11.4Bup 5.0%23 Oct 2020
28 Jun 2020$10.8Bup 2.1%24 Jul 2020
29 Mar 2020$11.1Bup 8.7%29 Apr 2020
29 Dec 2019$10.5Bup 3.5%18 Feb 2020
29 Sep 2019$10.9Bup 5.1%28 Oct 2019
30 Jun 2019$10.5Bup 1.7%29 Jul 2019
31 Mar 2019$10.2Bup 4.1%1 May 2019
30 Dec 2018$10.2Bup 5.3%20 Feb 2019
30 Sep 2018$10.3Bup 6.7%31 Oct 2018
1 Jul 2018$10.4Bup 19.9%2 Aug 2018
1 Apr 2018$9.8Bup 19.4%1 May 2018
31 Dec 2017$9.7B—21 Feb 2018
1 Oct 2017$9.7B—2 Nov 2017
2 Jul 2017$8.6B—3 Aug 2017
2 Apr 2017$8.2B—8 May 2017
28 Dec 2014$8.0Bup 9.6%24 Feb 2015

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Johnson & Johnson: MedTech worldwide operational sales (change on a year) · Oncology revenue · Immunology revenue · Neuroscience revenue · Cardiovascular revenue · Pulmonary Hypertension revenue · Cardiovascular/Metabolism/Other revenue · Infectious Diseases revenue · Shockwave revenue · MEDTECH revenue · United States revenue · Non-US revenue · Europe revenue · Asia-Pacific, Africa revenue · Western Hemisphere, excluding U.S. revenue · financial statements

Every KPI and segment of JNJ, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.